Term ended Jul 5, 2025 · High confidence
Held by Oriel Therapeutics, Inc.
Filed Mar 26, 2010 as application 29/358,433 · Granted Jul 5, 2011
Base term, 14 years from grant
Today
Term ended Jul 5, 2025
2011
2026
Clock starts
Jul 5, 2011
Jul 5, 2011
Term ended
Jul 5, 2025
Jul 5, 2025
base term
after the term ends
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
14 years from grant
Base term
No maintenance fees are payable on this kind of patent.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its base term, 14 years from grant, with no adjustment for prosecution delay. No maintenance fees are payable on this kind of patent. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 14 years from grant | Granted Jul 5, 2011 | Jul 5, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Computed term end | The steps above, in order | Jul 5, 2025 | High confidence |
This family
| US D641,076 | this patent Jul 2025 | Jul 2025 |
| US D711,528 | In force Aug 2028 | Aug 2028 |
| US D745,660 | In force Dec 2029 | Dec 2029 |
3 of 4 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 12, 2010 Reel 24376, frame 874 | Buckner, Charles; Deaton, Daniel; Ruckdeschel, Thomas W. | Oriel Therapeutics, Inc. | Assignment of Assignor's Interest |
| May 12, 2010 Reel 24376, frame 892 | Godfrey, Cyan; Valentine, Andrew J.; Butler, Margaret F. | Insight Product Development | Assignment of Assignor's Interest |
| May 12, 2010 Reel 24376, frame 898 | Insight Product Development LLC | Oriel Therapeutics, Inc. | Assignment of Assignor's Interest |
| May 12, 2010 Reel 24376, frame 990 | Grunstad, Jerome A. | Phillips Plastics Corporation | Assignment of Assignor's Interest |
| May 12, 2010 Reel 24667, frame 351 | Phillips Plastics Corporation | Oriel Therapeutics, Inc. | Assignment of Assignor's Interest |
| Aug 24, 2011 Reel 26933, frame 863 | Oriel Therapeutics, Inc. | Oriel Therapeutics, Inc. | Correction in State of Incorporation from North Carolina to Delaware (COPY of Secretary of State Documents Showing Conversation Attached, 4 Pages) |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center
No maintenance fees are payable on this kind of patent, so the record carries no fee events.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Citations
81
later US patents cite this one
That is top 10% of design patents granted in 2011 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.